Virginia Espina

Virginia Espina

George Mason University

H-index: 58

North America-United States

About Virginia Espina

Virginia Espina, With an exceptional h-index of 58 and a recent h-index of 29 (since 2020), a distinguished researcher at George Mason University, specializes in the field of proteomics, breast cancer, tumor microenvironment, clinical laboratory medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

Compositions and methods for laser capture microdissection

Optimization of digital pathology through laser capture microdissection with a 405 nm laser

Dynamic phospho-proteogenomic analysis of gastric cancer cells suggests host immunity provides survival benefit

METHOD FOR INDUCING AND DETECTING SOLUBLE LOX-1 (sLOX-1) IN CULTURED BLOOD CLOTS

Laser capture microdissection visualization chemistry

Drug discovery efforts at George Mason University

Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to …

Binding domain mapping

Virginia Espina Information

University

Position

Research Associate Professor

Citations(all)

24003

Citations(since 2020)

8706

Cited By

19182

hIndex(all)

58

hIndex(since 2020)

29

i10Index(all)

116

i10Index(since 2020)

73

Email

University Profile Page

Google Scholar

Virginia Espina Skills & Research Interests

proteomics

breast cancer

tumor microenvironment

clinical laboratory medicine

Top articles of Virginia Espina

Compositions and methods for laser capture microdissection

2023/9/5

Optimization of digital pathology through laser capture microdissection with a 405 nm laser

Cancer Research

2024/3/22

Dynamic phospho-proteogenomic analysis of gastric cancer cells suggests host immunity provides survival benefit

medRxiv

2024

METHOD FOR INDUCING AND DETECTING SOLUBLE LOX-1 (sLOX-1) IN CULTURED BLOOD CLOTS

2023/12/28

Laser capture microdissection visualization chemistry

2023/11/30

Drug discovery efforts at George Mason University

SLAS Discovery

2023/9/1

Pilot clinical trial and phenotypic analysis in chemotherapy-pretreated, metastatic triple-negative breast cancer patients treated with oral TAK-228 and TAK-117 (PIKTOR) to …

Biomarker Research

2023/7/25

Binding domain mapping

2022/11/8

Evaluating the influence of Lactobacillus rhamnosus-derived extracellular vesicles on calcium deposition in early breast cancer

Cancer Research

2022/6/15

Laser Capture Proteomics: spatial tissue molecular profiling from the bench to personalized medicine

2021/10/3

Encouraging long‐term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high‐risk patients with resectable pancreatic carcinoma

2021/10

Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes (vol 10, 13944, 2020)

Scientific reports

2020/8/18

Local production of lactate, ribose phosphate, and amino acids by human triple-negative breast cancer

Med

2021/6/11

Protocol for the Mason: Health Starts Here prospective cohort study of young adult college students

BMC Public Health

2021/5/12

Dual inhibitory action peptidomimetic inhibitor for IL-33 and IL-1beta

2021/2/23

Proteomic analysis of cardioembolic and large artery atherosclerotic clots using reverse phase protein array technology reveals key cellular interactions within clot …

Cureus

2021/2/22

Abstract PS11-25: Pilot trial of priming with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency (DDRD) followed by cisplatin (cis) and nab paclitaxel …

Cancer Research

2021/2/15

Virginia Espina
Virginia Espina

H-Index: 29

Claudius Mueller
Claudius Mueller

H-Index: 18

Characterization and Validation of Arg286 Residue of IL-1RAcP as a Potential Drug Target for Osteoarthritis

Frontiers in Chemistry

2021/2/3

Virginia Espina
Virginia Espina

H-Index: 29

Alessandra Luchini
Alessandra Luchini

H-Index: 20

Effects of HER family–targeting tyrosine kinase inhibitors on antibody-dependent cell-mediated cytotoxicity in HER2-expressing breast cancer

Clinical Cancer Research

2021/2/1

Virginia Espina
Virginia Espina

H-Index: 29

Lance Liotta
Lance Liotta

H-Index: 56

See List of Professors in Virginia Espina University(George Mason University)